Opinion
An international research consortium including Brown University, the University of Melbourne, the University of North Texas, and Dr. Roman Palitsky of Emory University is seeking participants for the Post-Psychedelic Challenges Study, which examines the symptoms of difficulties after a trip and what contributes to their improvement.
At ICPR 2026 at the historic city ofin Haarlem in the Netherlands, the companies racing to turn psychedelics into approved medicines were nowhere to be found, leaving a hall full of researchers, clinicians, and one reimbursement-obsessed reporter to sit with the unglamorous question of how these treatments will ever actually reach a patient.
Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum arose tomorrow and said ENOUGH of vitriol and demonization, suspicion and media-induced bitterness and hatred and instead received information from their higher selves rather than from divisive devices and screaming screens?
Ismail Lourido Ali, JD, Co-Executive Director of The Multidisciplinary Association for Psychedelic Studies (MAPS), offers thoughts on what to watch out for in the psychedelic sector in 2026.
Essayist Jim Tate warns psychedelic journalists who become high-profile influencers that drifting from rigorous, evidence-based reporting can impact the safety of people who seek experiences with substances that can affect their mental health.
Journalist Don Lattin writes that a new study examining the impact of psychedelic use on religious experiences supports his view that much of psychedelic research and journalism takes place in an echo chamber of self-reinforcing beliefs.
Consumer products marketed as containing psilocybin or other psychedelics are often mislabeled, and may instead contain potentially harmful synthetic compounds that evade fragmented regulatory frameworks.
The U.S. military attacks on alleged drug boats do nothing to address the dangers posed by illegal drugs and are instead being used as a pretext for possible land invasions and the further erosion of civil liberties that could target drug users in the U.S.
Author Erik Davis argues that some Christians resist demonizing psychedelics and are reaching across the ideological divide to acknowledge that these substances can spark sacred encounters and ease suffering.
From DMT vapes to MDMA gummies, psilocybin mushroom chocolate bars, and LSD microdots, an expanding range of psychedelic Consumer Packaged Goods (CPG) products is becoming increasingly available in the U.S. and Europe.
